Skip to main content
PMC home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1989 Jan;82(1):2–3. doi: 10.1177/014107688908200102

Colorectal liver metastases: is 'no treatment' still best?

T G Allen-Mersh 1
PMCID: PMC1291951  PMID: 2522549

Full text

PDF
2

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen-Mersh T. G., Kemeny N., Niedzwiecki D., Shurgot B., Daly J. M. Significance of a fall in serum CEA concentration in patients treated with cytotoxic chemotherapy for disseminated colorectal cancer. Gut. 1987 Dec;28(12):1625–1629. doi: 10.1136/gut.28.12.1625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ansfield F. J., Ramirez G., Davis H. L., Jr, Wirtanen G. W., Johnson R. O., Bryan G. T., Manalo F. B., Borden E. C., Davis T. E., Esmili M. Further clinical studies with intrahepatic arterial infusion with 5-fluorouracil. Cancer. 1975 Dec;36(6 Suppl):2413–2417. doi: 10.1002/1097-0142(197512)36:6<2413::aid-cncr2820360621>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  3. August D. A., Ottow R. T., Sugarbaker P. H. Clinical perspective of human colorectal cancer metastasis. Cancer Metastasis Rev. 1984;3(4):303–324. doi: 10.1007/BF00051457. [DOI] [PubMed] [Google Scholar]
  4. Balch C. M., Urist M. M., Soong S. J., McGregor M. A prospective phase II clinical trial of continuous FUDR regional chemotherapy for colorectal metastases to the liver using a totally implantable drug infusion pump. Ann Surg. 1983 Nov;198(5):567–573. doi: 10.1097/00000658-198311000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cady B., Oberfield R. A. Regional infusion chemotherapy of hepatic metastases from carcinoma of the colon. Am J Surg. 1974 Feb;127(2):220–227. doi: 10.1016/0002-9610(74)90161-5. [DOI] [PubMed] [Google Scholar]
  6. Carter S. K. Editorial: Large-bowel cancer-The current status of treatment. J Natl Cancer Inst. 1976 Jan;56(1):3–10. doi: 10.1093/jnci/56.1.3. [DOI] [PubMed] [Google Scholar]
  7. Cohen A. M., Kaufman S. D., Wood W. C. Treatment of colorectal cancer hepatic metastases by hepatic artery chemotherapy. Dis Colon Rectum. 1985 Jun;28(6):389–393. doi: 10.1007/BF02560217. [DOI] [PubMed] [Google Scholar]
  8. Daly J. M., Butler J., Kemeny N., Yeh S. D., Ridge J. A., Botet J., Bading J. R., DeCosse J. J., Benua R. S. Predicting tumor response in patients with colorectal hepatic metastases. Ann Surg. 1985 Sep;202(3):384–393. doi: 10.1097/00000658-198509000-00017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ensminger W. D., Gyves J. W. Clinical pharmacology of hepatic arterial chemotherapy. Semin Oncol. 1983 Jun;10(2):176–182. [PubMed] [Google Scholar]
  10. Ensminger W. D., Rosowsky A., Raso V., Levin D. C., Glode M., Come S., Steele G., Frei E., 3rd A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil. Cancer Res. 1978 Nov;38(11 Pt 1):3784–3792. [PubMed] [Google Scholar]
  11. Fortner J. G., Silva J. S., Golbey R. B., Cox E. B., Maclean B. J. Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg. 1984 Mar;199(3):306–316. doi: 10.1097/00000658-198403000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hohn D. C., Rayner A. A., Economou J. S., Ignoffo R. J., Lewis B. J., Stagg R. J. Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion. Cancer. 1986 Feb 1;57(3):465–470. doi: 10.1002/1097-0142(19860201)57:3<465::aid-cncr2820570311>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  13. Jaffe B. M., Donegan W. L., Watson F., Spratt J. S., Jr Factors influencing survival in patients with untreated hepatic metastases. Surg Gynecol Obstet. 1968 Jul;127(1):1–11. [PubMed] [Google Scholar]
  14. Kemeny N., Daly J., Reichman B., Geller N., Botet J., Oderman P. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. Ann Intern Med. 1987 Oct;107(4):459–465. doi: 10.7326/0003-4819-107-4-459. [DOI] [PubMed] [Google Scholar]
  15. Kemeny N., Yagoda A., Braun D., Jr Metastatic colorectal carcinoma. A prospective randomized trial of Methyl-CCNU, 5-Fluorouracil (5-FU) and vincristine (MOF) versus MOF plus streptozotocin (MOF-Strep). Cancer. 1983 Jan 1;51(1):20–24. doi: 10.1002/1097-0142(19830101)51:1<20::aid-cncr2820510106>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  16. Taylor I., Machin D., Mullee M., Trotter G., Cooke T., West C. A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer. Br J Surg. 1985 May;72(5):359–363. doi: 10.1002/bjs.1800720509. [DOI] [PubMed] [Google Scholar]
  17. Viadana E., Bross I. D., Pickren J. W. The metastatic spread of cancers of the digestive system in man. Oncology. 1978;35(3):114–126. doi: 10.1159/000225269. [DOI] [PubMed] [Google Scholar]
  18. Wagner J. S., Adson M. A., Van Heerden J. A., Adson M. H., Ilstrup D. M. The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg. 1984 May;199(5):502–508. doi: 10.1097/00000658-198405000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Welch J. P., Donaldson G. A. The clinical correlation of an autopsy study of recurrent colorectal cancer. Ann Surg. 1979 Apr;189(4):496–502. doi: 10.1097/00000658-197904000-00027. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES